Summary of Purpose
The central questions of the study can be summarized as follows: What stroke / death rates are the result of the use of the following treatment strategies: no anticoagulation with vitamin-k-antagonists (VKAs) or novel oral anticoagulants (NOACs), anticoagulation with VKAs and anticoagulation with NOACs (all). What other thromboembolic complication rates resulting from the use of these treatment strategies? What...Read More →
The following dates are available for this trial. Trial information last updated on 13 January 2016.
|1 Dec 2015||11 Jan 2016||1 Dec 2015||Unavailable||1 Jan 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Retrospective
- Sampling: Non-Probability Sample